Structured Summary
Abstract
A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
7 entry terms
- 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
- Merrem
- Penem
- Ronem
- SM 7338
- SM-7338
- SM7338
MeSH Record
Aspects Covered
25 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2019 (1989)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Meropenem. Medical Subject Headings (MeSH). 2026. Unique ID D000077731. http://id.nlm.nih.gov/mesh/2026/D000077731
- Meropenem. In: Wikipedia. https://en.wikipedia.org/wiki/Meropenem
- Meropenem. In: Wikidata. https://www.wikidata.org/wiki/Q421670